Rizzi, m., messina, g., penner, f., d'ammando, a., muratorio, f., franzini, a.Internal pulse generators in deep brain stimulation: rechargeable or not? an economical study.World neurosurgery.2015 may 30.Summary: deep brain stimulation (dbs) is a cost-effective strategy for the treatment of different neurological disorders.Nevertheless dbs procedures are burdened by the high costs of implantation and internal pulse generator (ipg) replacement.Different companies propose the use of rechargeable ipgs (rc-ipgs).The aim of our study is to compare the implantation costs of non-rc ipgs versus the estimated costs of rc-ipgs, in order to evaluate if an economical advantage for the health system could derive, in different categories of patients.One hundred and forty nine patients who underwent surgical procedure of ipg substitution were considered.A hypothetic scenario was realized in which the rechargeable ipgs were implanted instead of non-rc ipgs, at the time of dbs system implantation.Moreover, another scenario was outlined in a perspective period of time, corresponding to the patients' life-expectancy.Costs were calculated and inferential analysis performed.Results a savings of (b)(4), including the cost of complications management, was calculated during follow-up period of 7,9 years.In a comprehensive life-expectancy period of 47 years, a saving of (b)(4) would have been obtained (p <(><<)>0.05).Long-term groups data points out that a relevant savings would be expected from rc-ipgs implantation in the dystonic patients (p<(><<)>0.05), in patients with parkinson's disease (p<(> <<)>0.05) and it is projected to occur also in other categories of patients (p<(><<)>0.05).Rc-ipgs implantation presents different clinical advantages, if compared to non-rc devices.Huge economical resources can be spared with the implantation of rc ipgs, in categories of patients implanted with dbs.Reported event(s): 1.2 patients with deep brain stimulation (dbs) for dystonia experienced complications following a non-rechargeable single channel implantable neurostimulator (ins) replacement.It was noted that these complications were ascribable to the ins substitution (ie erroneous connection of the extension cable to the ins and wound dehiscence with or without demonstrated infection).The source literature included the following device specifics: soletra, kinetra, activa sc and activa pc further information has been requested; a supplemental report will be submitted if additional information is received.
|
It was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events.Concomitant products: product id neu_ins_stimulator, lot # unknown, product type implantable neurostimulator; product id neu_unknown_lead, lot # unknown, product type lead.(b)(4).
|